Medicine
Ery-Ped 400 mg/5 mL oral suspension
Ery-Ped 400 mg/5 mL oral suspension is a prescription medicine containing Erythromycin for oral use, marketed by Azurity Pharmaceuticals, Inc. (formerly Arbor Pharmaceuticals), with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store Ery-Ped 200 and Ery-Ped 400, prior to mixing, below 86°F (30°C). After…
Key facts
- Active ingredient (INN)
- Erythromycin
- Brand
- Ery-Ped
- Strength
- 400 mg/5 mL
- Dosage form
- Oral suspension
- Route
- Oral
- Packs
- 100 mL
- Marketing authorisation holder
- Azurity Pharmaceuticals, Inc. (formerly Arbor Pharmaceuticals)
- Manufacturer
- Azurity Pharmaceuticals, Inc. (formerly Arbor Pharmaceuticals)
- Origin register
- US FDA, United States
- Storage
- Store Ery-Ped 200 and Ery-Ped 400, prior to mixing, below 86°F (30°C). After reconstitution, Ery-Ped 200 and Ery-Ped 400 must be stored at or below 77°F (25°C) and used within 35 days, refrigeration is not required.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- D10AF02 Erythromycin
- HS code (indicative)
- 3004.20Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 14 June 2012
- Identifiers
- RxCUI 686400, 686402, 686418 +1DailyMed set ID 04775721-ab87-4b66-808c-d67a21032385NDC 24338-130Application NDA050207
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 100 mL in 1 bottle | 24338-130-13 | Azurity Pharmaceuticals, Inc. (formerly Arbor Pharmaceuticals) | 14 June 2012 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 25 June 1964 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Erythromycin 400 mg/5 mL oral suspension.
Other strengths and forms of Erythromycin
Clinical summary
Erythromycin is a macrolide antimicrobial indicated in the treatment of infections caused by susceptible strains of the designated organisms in the diseases listed below, among other approved uses. MedsAcross supplies Erythromycin for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about ErythromycinFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Ery-Ped prescribing information (Azurity Pharmaceuticals, Inc. (formerly Arbor Pharmaceuticals)) · U.S. National Library of Medicine, DailyMed
Need Ery-Ped 400 mg/5 mL oral suspension for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.